«Standing on the Shoulders of Giants»

MAIVAN’s Vision for AI-Driven Orthopedic Care – as a Public Benefit Corporation

In the dynamic landscape of orthopedic surgery, the integration of artificial intelligence (AI) promises transformative advancements. At MAIVAN.ai, we are committed to harnessing the power of AI to enhance diagnostic precision, optimize treatment strategies, and improve surgical outcomes. Our approach is grounded in the philosophy of “standing on the shoulders of giants,” building upon the foundational expertise of industry leaders to propel orthopedic care into a new era.​

Collaborating with Industry Leaders

Central to our mission is our collaboration with Google and NVIDIA, two titans in the realms of cloud computing and AI technology. By integrating Google Cloud’s secure, scalable infrastructure with NVIDIA’s advanced AI and machine learning capabilities, we have developed a platform that seamlessly incorporates clinically validated AI solutions into existing orthopedic workflows. This synergy ensures that healthcare providers can access cutting-edge tools without disrupting their established practices.

Advancing Diagnostic Accuracy and Treatment Planning

Our platform offers AI-powered imaging analysis tools capable of automatically interpreting X-rays, CT scans, and MRI images. These tools enhance diagnostic accuracy by detecting fractures, identifying bone and joint abnormalities, and assessing disease progression. By providing precise, timely insights, we empower orthopedic surgeons to make informed decisions, ultimately improving patient outcomes.

Enhancing Surgical Planning and Decision Support

Beyond diagnostics, our AI solutions assist in pre-operative planning, virtual surgical rehearsals, and intraoperative decision-making. By analyzing patient-specific imaging data and surgical parameters, our tools offer personalized recommendations for surgical approaches, implant selection, and procedural steps. This level of tailored support enhances the precision and efficiency of orthopedic procedures, contributing to better patient care.

Ensuring Clinical Validation and Seamless Integration

Understanding the critical importance of trust and reliability in medical applications, we have established a community-driven approach to validate our AI algorithms. Collaborating with a global network of orthopedic surgeons, hospital centers, and industry partners, we ensure that our solutions meet the highest clinical standards. Furthermore, our platform is designed for seamless integration into existing hospital systems, minimizing workflow disruptions and facilitating widespread adoption.

A Vision for the Future

By building upon the expertise of industry leaders and focusing on clinically validated AI solutions, MAIVAN.ai aims to revolutionize orthopedic care. Our vision is to empower healthcare providers with AI tools that enhance diagnostic accuracy, streamline treatment planning, and improve surgical outcomes, ultimately leading to better patient care and reduced healthcare costs.​

As we continue to innovate and collaborate, we remain dedicated to transforming orthopedic surgery through the responsible and effective integration of artificial intelligence.

Investing in MAIVAN.ai PBC: Pioneering AI-Driven Orthopedic Care with a Public Benefit Mission

MAIVAN.ai stands at the forefront of integrating artificial intelligence (AI) into orthopedic healthcare, uniquely structured as a Public Benefit Corporation (PBC). This innovative approach not only positions MAIVAN.ai for substantial financial growth but also ensures a steadfast commitment to societal well-being.​

Market Opportunity

The global AI healthcare market is experiencing unprecedented growth, projected to expand from $19 billion in 2023 to nearly $190 billion by 2030, reflecting a compound annual growth rate (CAGR) of approximately 38-40%. Within this landscape, orthopedic care presents a significant opportunity, addressing the needs of over 1.7 billion individuals affected by musculoskeletal disorders worldwide. The digital musculoskeletal (MSK) care market alone is valued at $4.4 billion as of 2024, with an anticipated annual growth rate of 17.7%.

MAIVAN.ai’s Competitive Advantage

MAIVAN.ai distinguishes itself through several key strategies:​

1. Crowd-Validation: Utilizing a network of over 100,000 orthopedic surgeons to test algorithms before deployment, ensuring clinical relevance and safety.​
2. Comprehensive Platform: Offering a curated marketplace of AI solutions with integrated clinician feedback loops, fostering continuous improvement and adoption.​
3. Value-Based Model: Aligning revenue streams with patient outcomes, emphasizing efficacy over mere usage.​
4. Strategic Partnerships: Collaborating with esteemed organizations such as the European Federation of National Associations of Orthopaedics and Traumatology (EFORT), the American Orthopaedic Society for Sports Medicine (AOSSM), and technology leaders like Google and NVIDIA.

Technological Innovations

MAIVAN.ai’s platform integrates advanced technologies to enhance orthopedic care:​

• Privacy-Preserving Collaboration: Employing federated learning to train AI models without transferring sensitive patient data, maintaining confidentiality and compliance.​
• Seamless Integration: Ensuring compatibility with existing hospital systems, such as Picture Archiving and Communication Systems (PACS) and Electronic Health Records (EHRs), to facilitate smooth adoption.​
• AI Marketplace: Providing a centralized repository for various orthopedic AI solutions, streamlining access and implementation for healthcare providers.​
• Innovative Data Generation: Utilizing synthetic medical images to overcome data scarcity challenges, enhancing model training and accuracy.

Public Benefit Corporation Structure

As a PBC, MAIVAN.ai balances profit motives with a commitment to delivering tangible public benefits. This structure aligns corporate governance with societal impact, fostering trust among stakeholders and potentially reducing liability exposure for directors and officers when decisions prioritize social objectives alongside shareholder interests.

Investment Potential

Investing in MAIVAN.ai offers a compelling opportunity to participate in the rapidly expanding AI healthcare sector, particularly within orthopedic care. The company’s unique combination of technological innovation, strategic partnerships, and a mission-driven approach positions it for sustainable growth and meaningful societal impact.​

By supporting MAIVAN.ai, investors contribute to a future where AI enhances orthopedic diagnostics and treatments, leading to improved patient outcomes and more efficient healthcare delivery.